Prospect News: News for Harvard Drug Group, LLC

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with H > Issuers starting with H, BK only > All stories on Harvard Drug Group, LLC > Stories on Harvard Drug Group, LLC, BK only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Harvard Drug Group, LLC

9/4/2015	BKIG	S&P raises, withdraws Harvard Drug
6/5/2015	BK	S&P puts Harvard Drug on positive watch
7/30/2013	BK	S&P cuts Harvard Drug loan, rates new loan B
2/6/2013	BK	Market Commentary: Ellucian, Harvard, BakerCorp, NRG, Hubbard break; Freescale, Tervita, Kronos, Waupaca revised
1/29/2013	BK	Market Commentary: Alcatel, VWR break; Nine, Unifrax, Pharmaceutical Product, AlixPartners, Cole Haan reworked
1/29/2013	BK	Harvard Drug Group launches $300 million term loan repricing
1/28/2013	BK	Harvard Drug Group to hold lender call on Tuesday afternoon
10/4/2012	BK	Harvard Drug cuts spread on $345 million term B to Libor plus 475 bps
10/4/2012	BK	Market Commentary: Harvard, Deltek, Terex, Telx break; RadNet, Zayo, Gray TV, David's Bridal update deals
9/20/2012	BK	Harvard Drug launches $345 million term B at Libor plus 500 bps
9/20/2012	BK	Market Commentary: CNO Financial, BJ's, Atlantic Broadband break; primary active with multiple launches
9/19/2012	BK	S&P: Generic Drug loans B+
9/19/2012	BK	Harvard Drug $380 million facility includes $35 million revolver
9/18/2012	BK	Harvard Drug sets Thursday lender meeting for $345 million term loan
9/18/2012	BK	Market Commentary: Serta upsizes, slashes spread talk; Alkermes prices atop tightened talk; Truven brings repricing
4/26/2010	BK	Market Commentary: Intersil, Harvard Drug break; Dollar Thrifty rises; Open Mobile, Telcordia, PVH tweak deals
4/22/2010	BK	Harvard Drug tightens OID on $182 million of term loan debt to 99
4/22/2010	BK	Market Commentary: Prime Healthcare breaks; US Airways, UAL dip; PVH, Advantage Sales, Lamar, Harvard revise deals
4/7/2010	BK	S&P rates Harvard Drug loans B+
4/7/2010	BK	Moody's rates Generic Drug loans B1
3/31/2010	BK	Market Commentary: American General unveils $2 billion loan; Securus sets talk; Harvard Drug to launch next week
3/31/2010	BK	Harvard Drug to launch $202 million facility via Credit Suisse, UBS

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.